Delivery Order SPE2DB20D2104-SPE2DB24FU90S

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $8,128.90 order is for the delivery of Bumetanide 0.5 mg tablets and has a performance period through March 13, 2024. Amerisourcebergen Drug Corp holds a single-award indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The awarded delivery order, valued at $2,843.27, is for 4,567,556,214 dicyclomine 20 mg tablets. This contract...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,030.08 and is for the delivery of various pharmaceutical products and medical supplies to support military treatment programs and facilities. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,256.57 with a completion date of July 22, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the procurement of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,235.12 firm fixed price contract is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,960.33 firm fixed-price contract, which has no set-aside designation, runs through December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The $1,933.41 firm-fixed-price contract is for the supply of various pharmaceutical products and medical supplies to support military treatment facilities and other federal healthcare providers. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This federal contract award, valued at $13,515.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of "TABLOID 40 MG TABLET 25S", a medical product, with a period of performance through December 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $31,585.91, is for the procurement of a range of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price, delivery order type, with a period of performance through January 17, 2024. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,137.45 firm fixed-price contract is for the delivery of Sulfamethoxazole-TMP DS tablets, with a performance period through August 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU90S
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bumetanide 2 mg tablets. The delivery order, valued at $1,088.17, is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the government to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 12:39 PM